Business Wire
BusinessIntel and Sanmina Compete for AI Infrastructure Attention, as Investors Weigh Valuation and GrowthThe Apex TimesBusinessVisa’s China approval outlines a potential foothold in domestic payments, but execution risks remainThe Apex TimesBusinessGoldman Sachs’ quarterly net revenue jumps 23% on stronger equities trading, upbeat investment banking activityThe Apex TimesBusinessApple shares hit a record high as HomeView arrives and Apple reshapes its smart home pitchThe Apex TimesBusinessUnitedHealth lifts 2026 outlook after quarterly operating profit jumps 52%The Apex TimesBusinessEli Lilly’s Oct. 29 earnings are set to be overshadowed by retatrutide, analysts sayThe Apex TimesBusinessBlackRock Bet on Higher Treasury Yields, Challenging the Fed’s AssumptionsThe Apex TimesBusinessYahoo Finance questions whether Apple’s new smart home push will move the numbersThe Apex TimesBusinessJPMorgan Chase misses Q3 expectations as Dimon’s buyback plan takes center stageThe Apex TimesBusinessDimon points to global deficits as bank earnings season starts, per Yahoo Finance takeawaysThe Apex TimesBusinessPalantir Investors Grapple With a Big-Bet Price Target of $300 by 2028The Apex TimesBusinessJPMorgan, Wells Fargo and Citigroup report consumer resilience as higher borrowing costs persistThe Apex TimesBusinessIntel and Sanmina Compete for AI Infrastructure Attention, as Investors Weigh Valuation and GrowthThe Apex TimesBusinessVisa’s China approval outlines a potential foothold in domestic payments, but execution risks remainThe Apex TimesBusinessGoldman Sachs’ quarterly net revenue jumps 23% on stronger equities trading, upbeat investment banking activityThe Apex TimesBusinessApple shares hit a record high as HomeView arrives and Apple reshapes its smart home pitchThe Apex TimesBusinessUnitedHealth lifts 2026 outlook after quarterly operating profit jumps 52%The Apex TimesBusinessEli Lilly’s Oct. 29 earnings are set to be overshadowed by retatrutide, analysts sayThe Apex TimesBusinessBlackRock Bet on Higher Treasury Yields, Challenging the Fed’s AssumptionsThe Apex TimesBusinessYahoo Finance questions whether Apple’s new smart home push will move the numbersThe Apex TimesBusinessJPMorgan Chase misses Q3 expectations as Dimon’s buyback plan takes center stageThe Apex TimesBusinessDimon points to global deficits as bank earnings season starts, per Yahoo Finance takeawaysThe Apex TimesBusinessPalantir Investors Grapple With a Big-Bet Price Target of $300 by 2028The Apex TimesBusinessJPMorgan, Wells Fargo and Citigroup report consumer resilience as higher borrowing costs persistThe Apex TimesBusinessIntel and Sanmina Compete for AI Infrastructure Attention, as Investors Weigh Valuation and GrowthThe Apex TimesBusinessVisa’s China approval outlines a potential foothold in domestic payments, but execution risks remainThe Apex TimesBusinessGoldman Sachs’ quarterly net revenue jumps 23% on stronger equities trading, upbeat investment banking activityThe Apex TimesBusinessApple shares hit a record high as HomeView arrives and Apple reshapes its smart home pitchThe Apex TimesBusinessUnitedHealth lifts 2026 outlook after quarterly operating profit jumps 52%The Apex TimesBusinessEli Lilly’s Oct. 29 earnings are set to be overshadowed by retatrutide, analysts sayThe Apex TimesBusinessBlackRock Bet on Higher Treasury Yields, Challenging the Fed’s AssumptionsThe Apex TimesBusinessYahoo Finance questions whether Apple’s new smart home push will move the numbersThe Apex TimesBusinessJPMorgan Chase misses Q3 expectations as Dimon’s buyback plan takes center stageThe Apex TimesBusinessDimon points to global deficits as bank earnings season starts, per Yahoo Finance takeawaysThe Apex TimesBusinessPalantir Investors Grapple With a Big-Bet Price Target of $300 by 2028The Apex TimesBusinessJPMorgan, Wells Fargo and Citigroup report consumer resilience as higher borrowing costs persistThe Apex TimesBusinessIntel and Sanmina Compete for AI Infrastructure Attention, as Investors Weigh Valuation and GrowthThe Apex TimesBusinessVisa’s China approval outlines a potential foothold in domestic payments, but execution risks remainThe Apex TimesBusinessGoldman Sachs’ quarterly net revenue jumps 23% on stronger equities trading, upbeat investment banking activityThe Apex TimesBusinessApple shares hit a record high as HomeView arrives and Apple reshapes its smart home pitchThe Apex TimesBusinessUnitedHealth lifts 2026 outlook after quarterly operating profit jumps 52%The Apex TimesBusinessEli Lilly’s Oct. 29 earnings are set to be overshadowed by retatrutide, analysts sayThe Apex TimesBusinessBlackRock Bet on Higher Treasury Yields, Challenging the Fed’s AssumptionsThe Apex TimesBusinessYahoo Finance questions whether Apple’s new smart home push will move the numbersThe Apex TimesBusinessJPMorgan Chase misses Q3 expectations as Dimon’s buyback plan takes center stageThe Apex TimesBusinessDimon points to global deficits as bank earnings season starts, per Yahoo Finance takeawaysThe Apex TimesBusinessPalantir Investors Grapple With a Big-Bet Price Target of $300 by 2028The Apex TimesBusinessJPMorgan, Wells Fargo and Citigroup report consumer resilience as higher borrowing costs persistThe Apex Times
Back to front
Patient Capital highlights long-horizon upside case for Alphabet in 2026 investor letter
The Apex Times

THE APEX TIMES

Business/The Apex Times/Oct 13, 8:27 AM EDT

Patient Capital highlights long-horizon upside case for Alphabet in 2026 investor letter

In its third-quarter 2026 letter for the Patient Opportunity Equity Strategy, Baltimore-based Patient Capital Management pointed to Google and its parent, Alphabet, as an example of how a long-term approach can frame potential value as shares move through cycles.

A third-quarter 2026 investor letter from Patient Capital Management, a Baltimore-based asset manager, focused on its Patient Opportunity Equity Strategy and argued that long-horizon investing can create “asymmetric” upside potential in certain situations. Alphabet, the parent of Google, was singled out as one of the companies discussed in the letter.

The letter, published as an attachment associated with the Q3 2026 period, was made available for download through a market update distributed by Yahoo Finance. The update framed the discussion around the strategy’s premise, which centers on identifying opportunities where the downside is viewed as more limited than the upside if underlying developments play out.

While the Yahoo Finance write-up summarizes the premise, it does not provide a detailed breakdown of the specific financial assumptions or scenario ranges within the Patient Opportunity Equity Strategy in the material available here. As a result, readers do not get, from this report alone, the letter’s exact supporting metrics, valuation models, or quantified catalyst timelines.

What is clear from the published materials described in the update is that Patient Capital uses its strategy framework to evaluate companies over extended periods, emphasizing the possibility that market pricing can diverge from a company’s longer-run trajectory. Alphabet’s inclusion suggests the firm sees a path where competitive position, product execution, or capital allocation could translate into materially better-than-expected outcomes for equity holders.

Alphabet’s business mix adds natural context for long-term equity research. The company monetizes search and advertising, while also investing heavily in cloud infrastructure and artificial intelligence related products. That combination can make Alphabet a candidate for investors who believe durable demand and platform advantages can offset periods of cost pressure or ad-market volatility.

Still, the disclosed information in the market update is limited, and it does not reproduce the letter’s full argumentation. The available excerpt does not identify which particular Alphabet initiatives Patient Capital is most focused on, nor does it state whether the thesis is driven primarily by advertising economics, cloud growth, AI monetization, or cost and efficiency dynamics.

For investors and observers, the main takeaway is about framing rather than a specific forecast: Patient Capital’s Q3 2026 communication positions Alphabet as fitting the strategy’s “asymmetric upside” concept. To evaluate whether that view is grounded in concrete fundamentals, readers would need to review the full Patient Opportunity Equity Strategy letter itself.

Looking ahead, the near-term question is whether Patient Capital’s thesis will be supported by developments that the letter cites, such as progress in Alphabet’s key growth areas or shifts in operating performance. For now, the report offers an investment-style rationale and a company focus, but it does not, by itself, settle the debate on timing or valuation.

Why It Matters

  • Long-horizon letters can announcement how asset managers are thinking about major platforms like Google during changing market conditions.
  • “Asymmetric upside” language typically indicates an emphasis on scenario-based risk-reward rather than a single-point forecast, which can influence how portfolios are constructed.
  • Alphabet is a frequent focus for long-term investors because it spans multiple drivers, including advertising and cloud-related growth, alongside ongoing AI investment.
  • The practical value for other readers is guidance on what investors are watching, though the specific metrics and catalysts cannot be confirmed from the limited published update alone.

Sources

Key Facts

  • Patient Capital Management published a third-quarter 2026 investor letter for its Patient Opportunity Equity Strategy.
  • The letter was circulated through a Yahoo Finance market update on October 13, 2026.
  • Alphabet (GOOGL) was among the companies discussed in the letter.
  • The update frames Patient Capital’s approach as aiming for “asymmetric upside potential.”
  • The Yahoo Finance material describes the availability of the Q3 2026 letter for download but does not reproduce its full detailed thesis in the information provided here.

Technology Related

Oct 13, 10:38 AM EDT
The Apex Times

Palantir Investors Grapple With a Big-Bet Price Target of $300 by 2028

A new market note argues Palantir’s AI-linked software prospects could justify a far higher share price by the end of 2028, pointing to a strong recent rally and the broader growth narrative around AI software. The post, however, does not provide detailed valuation work or company-specific guidance to back the timetable.

Palantir Investors Grapple With a Big-Bet Price Target of $300 by 2028
The Apex Times
Oct 13, 10:29 AM EDT
The Apex Times

Apple tests a new angle on the smart home with HomeView, but details remain unclear

Apple’s latest smart-home push, HomeView, is being positioned as a practical way for users to monitor and manage home life, according to a new discussion on Yahoo Finance. Still, the company has not publicly laid out enough commercial and technical specifics to clarify how quickly it could move beyond a niche audience.

Apple tests a new angle on the smart home with HomeView, but details remain unclear
The Apex Times
Oct 13, 10:29 AM EDT
The Apex Times

Meta points to early momentum in its Muse push as executives tout AI progress

In a recent interview segment, Mark Zuckerberg and chief AI officer Alexandr Wang discussed Meta’s investment in Muse and its “frontier” AI efforts, saying the work is starting to show results, even as the company keeps many technical details and performance metrics off the record.

Meta points to early momentum in its Muse push as executives tout AI progress
The Apex Times
Patient Capital highlights long-horizon upside case for Alphabet in 2026 investor letter | The Apex Times